Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Peripheral Arterial Disease

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Peripheral Arterial Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, CG; Kang, JW; Kim, JK; Ko, GY; Kwon, TW; Lim, TH1
Arnaiz, J; Attenberger, UI; Haneder, S; Loewe, C; Michaely, HJ; Schoenberg, SO1

Trials

2 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Peripheral Arterial Disease

ArticleYear
Evaluation of contrast-enhanced magnetic resonance angiography (MRA) using Gd-DOTA compared with time-of-flight MRA in the diagnosis of clinically significant non-coronary arterial disease.
    European radiology, 2010, Volume: 20, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Coronary Artery Disease; Female; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Angiography; Male; Middle Aged; Organometallic Compounds; Peripheral Arterial Disease; Reproducibility of Results; Sensitivity and Specificity

2010
Comparison of 0.5 M gadoterate and 1.0 M gadobutrol in peripheral MRA: a prospective, single-center, randomized, crossover, double-blind study.
    Journal of magnetic resonance imaging : JMRI, 2012, Volume: 36, Issue:5

    Topics: Aged; Contrast Media; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heterocyclic Compounds; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Organometallic Compounds; Peripheral Arterial Disease; Reproducibility of Results; Sensitivity and Specificity

2012